Credit: Getty Images. The application was supported by data from a phase 3 trial that included 330 patients 6 to 17 years of age with functional constipation. The Food and Drug Administration (FDA) ...
The U.S. Food and Drug Administration (FDA) granted priority review to AbbVie (NYSE:ABBV) and Ironwood Pharmaceuticals' (NASDAQ:IRWD) application seeking expanded approval of Linzess (linaclotide) to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results